Peter Hammond

Co-Founder & Managing Director at Exto Partners

📍 Greater Sydney Area, Australia🔄 Updated September 2026💼 4 investments📅 23 years investing🗓 Last invested Dec 2013𝕏 @upgrade_to_unlock
Operator-angel🌍 Australia
4
Total investments
3
Early stage
1
Mid stage
0
Late stage
23y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2013
Tuned Global is the leading provider of B2B streaming technology solutions, powering some of the world’s most successful streaming services. We offer a one-stop shop for music, audio and video streaming, providing white-label streaming apps, streaming service APIs, music content delivery, playlisting tools and licensor reporting. The company’s web3-ready technology can also be used in the metaverse to create immersive music experiences. Tuned Global’s tech has been used by some of the biggest names in #music, #fitness, #gaming, #media, #telco, #medicine and beyond, including UFC Ultimate Sound, Line Music, Warner Music Group, Universal Music Group, Sony Music, True Digital Group, Pizza Hut, GMM Grammy, FanLabel, Delta Airlines and Lululemon. The company is headquartered in Melbourne, with teams in Sydney, London, Sweden, France and San Francisco.
mid stageMusicians
Investor
Oct 2009
BuildingIQ (ASX:BIQ) helps building owners and operators worldwide lower energy use, increase building operations efficiency, and improve occupant comfort. We make this happen through out 5i Platform of technology-enabled services that power a better Internet of Things (IoT) approach for buildings. We have proven to reduce HVAC energy costs and made significant improvements in LEED or NABERS ratings, increased market value, and we help facilities teams operate buildings at lower cost with a higher level of service. BuildingIQ’s technology and service platform is built on the five pillars of data capture analysis, advanced modeling, measurement & verification, closed loop predictive control, and expert human analysis. These five pillars enable our services to deliver an optimize balance of energy savings, operational efficiency, and tenant comfort. Our platform ingests multiple, large and disparate data streams from buildings, meters, and other data sources; it then translates and models, and performs predictive analytics to inform our —and our partners’— services. The 5i Platform’s structured API fuels BuildingIQ services as well as those from our technology partners. Over time, the platform leverages machine learning to evolve along with our customers’ buildings. BuildingIQ was spun out from Australia’s National Labs and works closely with the US National Labs. Investors in BuildingIQ include the Venture Capital unit of Siemens Financial Services, Paladin Capital and Exto Partners.
Investor
Dec 2006
The RedHill Group unites four progressive businesses committed to the provision of quality private education in Australia. Targeting both international and domestic markets, our investment in educational service means we offer a uniquely integrated approach. Students can remain with RedHill from the outset – from gaining assistance with lodging visas, understanding available study options – to completing a recognised quality course or programme. This business breadth allows us to maximise service levels to students and remain abreast of important developments in the industry. A core strength is our successful engagement and recruitment of students from multiple cultures and backgrounds. Our study options have broad appeal, covering academic, vocational, and leisure courses. It gives us great pride to see thousands of students fulfil their study goals every year. Our international focus allows us to better understand trends in global education services, and to focus our strategies to deliver business growth.
Investor
Mar 2003
Optalert developed the world’s leading algorithm to quantify the deterioration in cognitive brain function due to drowsiness and created the Johns Drowsiness Scale (JDS) which remains the only scientifically proven, objective measurement of drowsiness. The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland. Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement. Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.
early stageBiotechnology
Experience · 6 entries
All (6)
Investments (4)
Founder (1)
2013
Investor
Dec 2013
Tuned Global is the leading provider of B2B streaming technology solutions, powering some of the world’s most successful streaming services. We offer a one-stop shop for music, audio and video streaming, providing white-label streaming apps, streaming service APIs, music content delivery, playlisting tools and licensor reporting. The company’s web3-ready technology can also be used in the metaverse to create immersive music experiences. Tuned Global’s tech has been used by some of the biggest names in #music, #fitness, #gaming, #media, #telco, #medicine and beyond, including UFC Ultimate Sound, Line Music, Warner Music Group, Universal Music Group, Sony Music, True Digital Group, Pizza Hut, GMM Grammy, FanLabel, Delta Airlines and Lululemon. The company is headquartered in Melbourne, with teams in Sydney, London, Sweden, France and San Francisco.
mid stageMusicians
2009
Investor
Oct 2009
BuildingIQ (ASX:BIQ) helps building owners and operators worldwide lower energy use, increase building operations efficiency, and improve occupant comfort. We make this happen through out 5i Platform of technology-enabled services that power a better Internet of Things (IoT) approach for buildings. We have proven to reduce HVAC energy costs and made significant improvements in LEED or NABERS ratings, increased market value, and we help facilities teams operate buildings at lower cost with a higher level of service. BuildingIQ’s technology and service platform is built on the five pillars of data capture analysis, advanced modeling, measurement & verification, closed loop predictive control, and expert human analysis. These five pillars enable our services to deliver an optimize balance of energy savings, operational efficiency, and tenant comfort. Our platform ingests multiple, large and disparate data streams from buildings, meters, and other data sources; it then translates and models, and performs predictive analytics to inform our —and our partners’— services. The 5i Platform’s structured API fuels BuildingIQ services as well as those from our technology partners. Over time, the platform leverages machine learning to evolve along with our customers’ buildings. BuildingIQ was spun out from Australia’s National Labs and works closely with the US National Labs. Investors in BuildingIQ include the Venture Capital unit of Siemens Financial Services, Paladin Capital and Exto Partners.
2006
Investor
Dec 2006
The RedHill Group unites four progressive businesses committed to the provision of quality private education in Australia. Targeting both international and domestic markets, our investment in educational service means we offer a uniquely integrated approach. Students can remain with RedHill from the outset – from gaining assistance with lodging visas, understanding available study options – to completing a recognised quality course or programme. This business breadth allows us to maximise service levels to students and remain abreast of important developments in the industry. A core strength is our successful engagement and recruitment of students from multiple cultures and backgrounds. Our study options have broad appeal, covering academic, vocational, and leisure courses. It gives us great pride to see thousands of students fulfil their study goals every year. Our international focus allows us to better understand trends in global education services, and to focus our strategies to deliver business growth.
2003
Owner
Mar 2003
Exto Partners is a diversified private investment firm. We invest in and work with both emerging and established companies to achieve their potential. We build high performance global businesses that focus on innovation, transform established industries and challenge existing market leaders to drive value for shareholders. Exto Partners has been operating for over 10 years and has a diversified investment portfolio.
Investor
Mar 2003
Optalert developed the world’s leading algorithm to quantify the deterioration in cognitive brain function due to drowsiness and created the Johns Drowsiness Scale (JDS) which remains the only scientifically proven, objective measurement of drowsiness. The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland. Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement. Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.
early stageBiotechnology
Show all 6 entries ↓
Investment activity
2003–2013 · 4 investments
20031200612009120131
Recent (last 2 years)Earlier